# Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV

> **NCT02590094** · NA · COMPLETED · sponsor: **Panhandle Eye Group, LLP** · enrollment: 568 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Intravitreal bevacizumab or intravitreal ziv-aflibercept

## Key facts

- **NCT ID:** NCT02590094
- **Lead sponsor:** Panhandle Eye Group, LLP
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2019-01-04
- **Final completion:** 2019-01-04
- **Target enrollment:** 568 (ACTUAL)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02590094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02590094, "Preoperative Bevacizumab and Ziv-Aflibercept Administration in PDR Subjects Undergoing PPV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02590094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*